Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Oral and Maxillofacial Pathology · Oral Leukoplakia

Oral Leukoplakia Pathology: Should I Get a Second Opinion?

At a Glance

A second opinion on an oral leukoplakia biopsy is especially useful when the report conflicts with the lesion’s appearance, shows high-grade changes, suggests cancer or a high-risk form, or guides treatment. Suspected cancer needs prompt specialist care while the slides are reviewed.

Waiting for pathology results can be incredibly anxious, and hearing that your biopsy results might need a second look can add to that uncertainty. A second opinion on an oral leukoplakia pathology report is not automatically required for every biopsy, but it is highly recommended in specific situations [1][2]. Because grading the cellular changes in these lesions can be subjective, having an experienced oral and maxillofacial pathologist—a specialist in diseases of the mouth and jaws—review your slides can provide valuable clarity [1][2].

A second review is especially useful if the biopsy results do not match how the lesion looks to your doctor, if the report shows high-grade changes, if a high-risk subtype like proliferative verrucous leukoplakia (PVL) is suspected, or if the results will drive a major treatment decision [3][1].

Why is Dysplasia Grading Difficult?

When a pathologist looks at an oral leukoplakia biopsy, they are trying to determine if the cells show signs of oral epithelial dysplasia (premalignant cellular changes that indicate an increased risk of cancer) and how severe those changes are [3]. However, assigning a specific grade—such as mild, moderate, or severe dysplasia—is highly subjective. Research shows that different pathologists, even experts, can sometimes disagree on the dysplasia grade of the same biopsy sample [4][3].

Because of this natural variation, seeking a second opinion from an oral and maxillofacial pathologist at a specialist or academic center can help reduce uncertainty [1][3]. A different grade on a second opinion does not automatically mean the first pathologist made a mistake; it simply reflects the complex nature of interpreting these cellular changes [3]. Reaching a consensus among experts is often the best approach [3].

When to Consider a Second Opinion

Discuss getting a pathology second opinion with your care team if you fall into any of the following categories:

  • Disagreement Between Clinical Appearance and Pathology: If your doctor is highly concerned about the lesion because it is non-homogeneous (an uneven, mixed red-and-white, or ulcerated appearance), but the biopsy comes back as “no dysplasia” or “mild dysplasia,” a reassessment is warranted [5][6]. Note that if a small incisional biopsy missed the most abnormal area, a second look at the same slides won’t fix the sampling error [7]. In this case, your doctor may recommend a new or mapping biopsy rather than just a second opinion on the old slides [7][6].
  • High-Grade Findings: If your report indicates severe dysplasia, carcinoma in situ (highly abnormal cells that have not yet invaded deeper tissues), or suspects invasive cancer, a specialist review can confirm these findings [3][8]. Important: Do not delay urgent specialist care to wait for a second opinion [9]. If your report mentions suspected cancer, your review and treatment planning should happen promptly and in parallel through a head-and-neck specialist or oral surgeon [9][10].
  • Major Treatment Decisions: A specialist review can ensure you are making the most informed choice if the pathology grade is driving a major decision [11]. However, treatment is never based on grade alone [12]. Your care team will also consider the lesion’s size, location, your risk factors (like tobacco use), and whether you can commit to a structured surveillance plan [13][12].
  • Suspected Proliferative Verrucous Leukoplakia (PVL): PVL is a rare, progressive, and high-risk clinicopathologic disorder [14]. Early on, PVL biopsies can look completely harmless or show only low-grade changes [14][15]. Because a single biopsy cannot confirm or rule out PVL, an expert review of your complete timeline, lesion photographs, and all prior pathology by a specialized team is strongly recommended [16][17].

How Does a Pathology Second Opinion Work?

Your treating clinician or the original pathology department usually coordinates the second opinion [2]. They will request that the stained glass slides and tissue samples (paraffin blocks) from your first biopsy be sent to a reviewing service [2].

The reviewing pathologist will look at the tissue and will often ask for clinical photographs of the lesion, a description of exactly where the biopsy was taken, and your history of tobacco or alcohol use [5]. This is called clinicopathologic correlation, and it is essential because how the lesion looks and behaves in your mouth helps the pathologist interpret what they see on the slide [5][18].

Even if a second opinion downgrades your diagnosis or finds no dysplasia, pathology review is not a substitute for clinical exams [6]. You must continue your structured follow-up and surveillance plan [6][19].

Common questions in this guide

When might an oral leukoplakia biopsy deserve a second opinion?
Expert review is especially useful when the pathology result does not match how the lesion looks, shows high-grade dysplasia or carcinoma in situ, suggests invasive cancer, or will drive a major treatment decision. It is also recommended when proliferative verrucous leukoplakia, a high-risk form of leukoplakia, is suspected.
Can a second opinion fix a biopsy that sampled the wrong spot?
No. Reviewing the same slides cannot correct a sampling error if a small biopsy missed the most abnormal area; your clinician may recommend a new or mapping biopsy instead.
What does an oral and maxillofacial pathologist need for a second review?
The reviewer usually needs the stained slides and tissue blocks from the original biopsy, along with photos of the lesion, the exact biopsy site, and relevant tobacco or alcohol history. Comparing the slide findings with the lesion’s appearance and history is called clinicopathologic correlation and helps put the report in context.
Should I delay cancer care while waiting for a pathology review?
No. If the report suggests cancer, seek prompt evaluation from a head-and-neck specialist or oral surgeon while the second review and treatment planning proceed in parallel.
Why might two pathologists assign different dysplasia grades?
Grading oral epithelial dysplasia involves judgment, so qualified pathologists may disagree about whether changes are mild, moderate, or severe. A different grade does not automatically mean the first report was wrong; your team may use expert consensus, the lesion’s appearance, and your risk factors to guide care.
Do I still need follow-up if a second opinion finds no dysplasia?
Yes. A reassuring pathology review does not replace regular clinical examinations because the biopsy may not represent every part of the lesion, so follow the surveillance schedule recommended by your care team and report new changes promptly.

Get notified when new evidence is published on oral mucosa leukoplakia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (19)
  1. 1

    Demystifying oral epithelial dysplasia: a histological guide.

    Hankinson P, Mahmood H, Walsh H, et al.

    Pathology 2024; (56(1)):11-23 doi:10.1016/j.pathol.2023.10.002.

    PMID: 38030478
  2. 2

    Oral Epithelial Dysplasia: A Review of Diagnostic Criteria for Anatomic Pathologists.

    Cheung VKY, Hulme K, Schifter M, et al.

    Advances in anatomic pathology 2022; (29(4)):227-240 doi:10.1097/PAP.0000000000000343.

    PMID: 35435865
  3. 3

    The clinical utility of contemporary oral epithelial dysplasia grading systems.

    Sathasivam HP, Sloan P, Thomson PJ, Robinson M

    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 2022; (51(2)):180-187 doi:10.1111/jop.13262.

    PMID: 34797585
  4. 4

    A head-to-head comparison of four grading systems for oral epithelial dysplasia.

    Hankinson P, Clark M, Walsh H, Khurram SA

    Histopathology 2025; (86(6)):933-941 doi:10.1111/his.15400.

    PMID: 39688116
  5. 5

    Clinico-Pathological Assessment and Malignant Transformation in Patients with Oral Epithelial Dysplasia - A Follow-up Cohort Study.

    Yasothkumar D, Ramani P, Ramasubramanian A

    Head and neck pathology 2025; (19(1)):96 doi:10.1007/s12105-025-01833-8.

    PMID: 40758174
  6. 6

    Oral Leukoplakia and Risk of Progression to Oral Cancer: A Population-Based Cohort Study.

    Chaturvedi AK, Udaltsova N, Engels EA, et al.

    Journal of the National Cancer Institute 2020; (112(10)):1047-1054 doi:10.1093/jnci/djz238.

    PMID: 31860085
  7. 7

    Diagnostic discrepancies in the surgical management of oral epithelial dysplasia - an analysis of concordance between incisional biopsy and definitive resection specimens.

    Maloney B, Jung MS, Byrne J, et al.

    Oral surgery, oral medicine, oral pathology and oral radiology 2026; (142(3)):362-374 doi:10.1016/j.oooo.2026.03.001.

    PMID: 42020233
  8. 8

    Oral epithelial dysplasia: Recognition, grading and clinical significance.

    Odell E, Kujan O, Warnakulasuriya S, Sloan P

    Oral diseases 2021; (27(8)):1947-1976 doi:10.1111/odi.13993.

    PMID: 34418233
  9. 9

    Oral epithelial dysplasia, atypical verrucous lesions and oral potentially malignant disorders: focus on histopathology.

    Müller S

    Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):591-602 doi:10.1016/j.oooo.2018.02.012.

    PMID: 29606637
  10. 10

    Clinical features and presentation of oral potentially malignant disorders.

    Warnakulasuriya S

    Oral surgery, oral medicine, oral pathology and oral radiology 2018; (125(6)):582-590 doi:10.1016/j.oooo.2018.03.011.

    PMID: 29673799
  11. 11

    Malignant transformation of oral leukoplakia: a follow-up study.

    Jayasooriya PR, Dayaratne K, Dissanayake UB, Warnakulasuriya S

    Clinical oral investigations 2020; (24(12)):4563-4569 doi:10.1007/s00784-020-03322-4.

    PMID: 32436158
  12. 12

    Oral leukoplakia diagnosis and treatment in Europe and Australia: Oral Medicine Practitioners' attitudes and practice.

    Pentenero M, Sutera S, Lodi G, et al.

    Oral diseases 2023; (29(8)):3214-3222 doi:10.1111/odi.14301.

    PMID: 35792047
  13. 13

    Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?

    Pritzker KPH, Darling MR, Hwang JT, Mock D

    Expert review of molecular diagnostics 2021; (21(3)):289-298 doi:10.1080/14737159.2021.1898949.

    PMID: 33682567
  14. 14

    A Scoping Review on Gaps in the Diagnostic Criteria for Proliferative Verrucous Leukoplakia: A Conceptual Proposal and Diagnostic Evidence-Based Criteria.

    González-Moles MÁ, Ramos-García P, Warnakulasuriya S

    Cancers 2021; (13(15)) doi:10.3390/cancers13153669.

    PMID: 34359571
  15. 15

    Proliferative Verrucous Leukoplakia: An Expert Consensus Guideline for Standardized Assessment and Reporting.

    Thompson LDR, Fitzpatrick SG, Müller S, et al.

    Head and neck pathology 2021; (15(2)):572-587 doi:10.1007/s12105-020-01262-9.

    PMID: 33415517
  16. 16

    Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

    Staines K, Rogers H

    British dental journal 2017; (223(9)):655-661 doi:10.1038/sj.bdj.2017.881.

    PMID: 29097794
  17. 17

    Inter-observer Variability in the Diagnosis of Proliferative Verrucous Leukoplakia: Clinical Implications for Oral and Maxillofacial Surgeon Understanding: A Collaborative Pilot Study.

    Upadhyaya JD, Fitzpatrick SG, Cohen DM, et al.

    Head and neck pathology 2020; (14(1)):156-165 doi:10.1007/s12105-019-01035-z.

    PMID: 30972634
  18. 18

    Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.

    Jäwert F, Pettersson H, Jagefeldt E, et al.

    International journal of oral and maxillofacial surgery 2021; (50(11)):1422-1428 doi:10.1016/j.ijom.2021.01.012.

    PMID: 33674140
  19. 19

    Follow-up study of veterans with white and red oral mucosal lesions at Veterans Affairs Dental Clinics.

    Redman RS, Diehl SR, Jones-Richardson T, et al.

    Clinical and experimental dental research 2023; (9(1)):82-92 doi:10.1002/cre2.677.

    PMID: 36510634

This page discusses when an oral leukoplakia pathology report may benefit from expert review for informational purposes only; it does not constitute medical advice. Ask your dentist, pathologist, oral surgeon, or head-and-neck specialist about your own results and any urgent next steps.